CreativeOne Wealth’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$534K Buy
6,666
+3,510
+111% +$289K 0.01% 782
2025
Q4
$269K Sell
3,156
-93
-3% -$7.63K 0.01% 997
2025
Q3
$253K Buy
3,249
+556
+21% +$43.4K 0.01% 1018
2025
Q2
$211K Buy
+2,693
New +$201K 0.01% 1041
2025
Q1
Sell
-2,715
Closed -$201K 1092
2024
Q4
$201K Buy
+2,715
New +$190K 0.01% 1019
2024
Q1
Sell
-5,445
Closed -$415K 883
2023
Q4
$415K Sell
5,445
-1,177
-18% -$81.9K 0.03% 413
2023
Q3
$459K Sell
6,622
-2,556
-28% -$205K 0.03% 348
2023
Q2
$866K Sell
9,178
-3,571
-28% -$310K 0.04% 354
2023
Q1
$1.05M Buy
12,749
+1,052
+9% +$82.7K 0.05% 297
2022
Q4
$873K Sell
11,697
-275
-2% -$21.2K 0.05% 306
2022
Q3
$989K Buy
11,972
+282
+2% +$27.1K 0.06% 263
2022
Q2
$1.11M Sell
11,690
-5,099
-30% -$528K 0.06% 242
2022
Q1
$1.98M Buy
16,789
+736
+5% +$82.6K 0.1% 163
2021
Q4
$2.08M Buy
16,053
+2,190
+16% +$255K 0.1% 181
2021
Q3
$1.57M Buy
13,863
+4,796
+53% +$547K 0.09% 191
2021
Q2
$939K Buy
9,067
+1,794
+25% +$169K 0.06% 264
2021
Q1
$609K Buy
+7,273
New +$615K 0.05% 299
2020
Q4
Sell
-2,482
Closed -$198K 510
2020
Q3
$198K Buy
+2,482
New +$194K 0.03% 258

Other funds holding EW

CreativeOne Wealth's EW Position: Q1 2026 in Review

CreativeOne Wealth increased its Edwards Lifesciences (EW) stake by 111% in Q1 2026, buying an estimated $289K and bringing the position to 6,666 shares worth $534K. The position accounts for 0.01% of the portfolio, ranked #782.

CreativeOne Wealth first reported a position in EW in Q3 2020 and has held it in 18 quarters since. The position peaked at $2.08M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • CreativeOne Wealth held 6,666 shares of Edwards Lifesciences worth $534K as of Q1 2026.
  • CreativeOne Wealth bought 3,510 Edwards Lifesciences shares in Q1 2026, an estimated $289K.
  • Edwards Lifesciences made up 0.01% of CreativeOne Wealth's portfolio in Q1 2026, its #782 holding.
  • CreativeOne Wealth first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 18 quarters since.
  • CreativeOne Wealth's Edwards Lifesciences position peaked at $2.08M in Q4 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on CreativeOne Wealth's 13F filing for Q1 2026, filed 15 May 2026.